{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:57:50Z","timestamp":1794466670903,"version":"4.9.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjsurg.2026.117054","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:00:22Z","timestamp":1778860822000},"page":"117054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Contemporary management of unresectable or borderline operable colorectal cancer liver metastases: a review and modern treatment algorithm"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-9004","authenticated-orcid":false,"given":"Alexander S.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belain","family":"Eyob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5306\/wjco.v8.i3.190","article-title":"Multidisciplinary approach of colorectal cancer liver metastases","volume":"8","author":"Fiorentini","year":"2017","journal-title":"World J Clin Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","article-title":"Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies","volume":"94","author":"Simmonds","year":"2006","journal-title":"Br J Cancer"},{"issue":"22","key":"10.1016\/j.amjsurg.2026.117054_bib4","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"16","key":"10.1016\/j.amjsurg.2026.117054_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","article-title":"Metastatic colorectal cancer: current state and future directions","volume":"33","author":"Fakih","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.117054_bib7","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1097\/JS9.0000000000002727","article-title":"Differential prognostic impact of liver resection by the site of concurrent extrahepatic diseases in patients with colorectal cancer liver metastases: a nationwide multicenter study","volume":"111","author":"Kato","year":"2025","journal-title":"Int J Surg Lond Engl"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.117054_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2024.5174","article-title":"First-line systemic treatment for initially unresectable colorectal liver metastases: post hoc analysis of the CAIRO5 randomized clinical trial","volume":"11","author":"Bond","year":"2025","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bjs.7032","article-title":"Surgical management and outcomes of colorectal cancer liver metastases","volume":"97","author":"Morris","year":"2010","journal-title":"Br J Surg"},{"issue":"2 D","key":"10.1016\/j.amjsurg.2026.117054_bib11","article-title":"Colon cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Benson","year":"2024","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib12","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1245\/s10434-024-15187-y","article-title":"Outcomes of hepatic artery-based therapies and systemic multiagent chemotherapy in unresectable colorectal liver metastases: a systematic review and meta-analysis","volume":"31","author":"Sugumar","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib13","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/bjs\/znaa155","article-title":"Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial","volume":"108","author":"Liu","year":"2021","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(23)00219-X","article-title":"First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch colorectal cancer group","volume":"24","author":"Bond","year":"2023","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/SLA.0b013e3182a5025a","article-title":"RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases","volume":"258","author":"Vauthey","year":"2013","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.amjsurg.2026.117054_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00595-015-1113-7","article-title":"Post-hepatectomy liver failure in patients with colorectal liver metastases","volume":"45","author":"Narita","year":"2015","journal-title":"Surg Today"},{"issue":"27","key":"10.1016\/j.amjsurg.2026.117054_bib18","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.117054_bib19","first-page":"197","article-title":"Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma","volume":"33","author":"Min","year":"2013","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib20","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.21037\/jgo-21-96","article-title":"Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases","volume":"12","author":"Moslim","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000490111","article-title":"Liver resection for colorectal hepatic metastases after systemic chemotherapy and selective internal radiation therapy with Yttrium-90 microspheres: a systematic review","volume":"36","author":"Baltatzis","year":"2019","journal-title":"Dig Surg"},{"issue":"25","key":"10.1016\/j.amjsurg.2026.117054_bib22","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1200\/JCO.2008.20.8116","article-title":"Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic Irinotecan chemotherapy","volume":"27","author":"van Hazel","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.117054_bib23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.amjsurg.2026.117054_bib24","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.117054_bib25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.2008.19.9273","article-title":"Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?","volume":"27","author":"Adam","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","article-title":"Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review","volume":"129","author":"Petrelli","year":"2018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.amjsurg.2026.117054_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1117874","article-title":"MRI-LINAC: a transformative technology in radiation oncology","volume":"13","author":"Ng","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2025.102000","article-title":"The first international experience with histotripsy: a safety analysis of 230 cases","volume":"29","author":"Wehrle","year":"2025","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/SLA.0000000000006720","article-title":"The #HOPE4LIVER single-arm pivotal trial for histotripsy of primary and metastatic liver tumors: one-year update of clinical outcomes","volume":"282","author":"Ziemlewicz","year":"2025","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jso.24898","article-title":"Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential","volume":"117","author":"Pak","year":"2018","journal-title":"J Surg Oncol"},{"issue":"17","key":"10.1016\/j.amjsurg.2026.117054_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","article-title":"Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis","volume":"35","author":"Groot","year":"2017","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.hpb.2023.12.006","article-title":"Safety and feasibility of establishing an adjuvant hepatic artery infusion program","volume":"26","author":"Janczewski","year":"2024","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.117054_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yao.2024.11.002","article-title":"Hepatic artery infusion pump theory in resectable and unresectable liver tumors","volume":"5","author":"Janczewski","year":"2024","journal-title":"Adv Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.117054_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","article-title":"Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure","volume":"15","author":"Boige","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.117054_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.20286","article-title":"Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma","volume":"91","author":"Kemeny","year":"2005","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.117054_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes","volume":"261","author":"D\u02bcAngelica","year":"2015","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.amjsurg.2026.117054_bib38","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1245\/s10434-019-07973-w","article-title":"Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases: results of a safety and feasibility study in the Netherlands","volume":"26","author":"Buisman","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.surg.2018.01.004","article-title":"Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?","volume":"163","author":"Creasy","year":"2018","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.117054_bib40","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1245\/s10434-013-3009-3","article-title":"Conversion to complete resection and\/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution","volume":"20","author":"Ammori","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.117054_bib41","first-page":"1203","article-title":"Hepatic artery infusion pump for unresectable colorectal liver metastases before living donor liver transplant: oncological friend or technical foe?","volume":"30","author":"Goldaracena","year":"2024","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.117054_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial","volume":"26","author":"van der Lei","year":"2025","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers17040640","article-title":"RAS-beppu classification: a new recurrence risk classification system incorporating the beppu score and RAS status for colorectal liver metastases","volume":"17","author":"Tajiri","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.21037\/hbsn-2025-238","article-title":"De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial","volume":"14","author":"Albuquerque","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib46","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/cancers12071779","article-title":"Resectability and ablatability criteria for the treatment of liver only colorectal metastases: multidisciplinary consensus document from the COLLISION trial group","volume":"12","author":"Nieuwenhuizen","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.117054_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SLA.0000000000002319","article-title":"RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases","volume":"269","author":"Brudvik","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib49","first-page":"1499","article-title":"Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study","volume":"20","author":"Kemeny","year":"2002","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jso.20463","article-title":"A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy","volume":"93","author":"Martin","year":"2006","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.117054_bib51","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/annonc\/mdn769","article-title":"Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer","volume":"20","author":"Kemeny","year":"2009","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00000658-200012000-00006","article-title":"Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors","volume":"232","author":"Adam","year":"2000","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1477-2574.2010.00161.x","article-title":"Two-stage strategy for patients with extensive bilateral colorectal liver metastases","volume":"12","author":"Tsai","year":"2010","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/SLA.0b013e3181907fd9","article-title":"Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases","volume":"248","author":"Wicherts","year":"2008","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00268-017-4181-6","volume":"42","author":"Moris","year":"2018","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.sla.0000145965.86383.89","article-title":"A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases","volume":"240","author":"Jaeck","year":"2004","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.117054_bib57","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/bjs.5836","article-title":"Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome","volume":"94","author":"Ribero","year":"2007","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/SLA.0b013e31815ed693","article-title":"Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases","volume":"247","author":"Covey","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2026.117054_bib59","article-title":"Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial","volume":"53","author":"Korenblik","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","article-title":"Early survival and safety of ALPPS: first report of the international ALPPS registry","volume":"260","author":"Schadde","year":"2014","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib61","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0000000000001450","article-title":"Prediction of mortality after ALPPS Stage-1: an analysis of 320 patients from the international ALPPS registry","volume":"262","author":"Schadde","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib62","article-title":"Long-term Follow-Up of patients with advanced colorectal liver metastasis: a survival analysis from the randomized controlled multicenter trial LIGRO","volume":"5","author":"Bj\u00f6rk","year":"2024","journal-title":"Ann Surg Open Perspect Surg Hist Educ Clin Approaches"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.surg.2017.09.044","article-title":"Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy","volume":"163","author":"Wanis","year":"2018","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib64","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","article-title":"Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?","volume":"261","author":"Dueland","year":"2015","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.117054_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.2932","article-title":"Long-term survival, prognostic factors, and selection of patients with colorectal cancer for liver transplant: a nonrandomized controlled trial","volume":"158","author":"Dueland","year":"2023","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.117054_bib66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"issue":"10458","key":"10.1016\/j.amjsurg.2026.117054_bib67","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","volume":"404","author":"Adam","year":"2024","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.117054_bib68","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1245\/s10434-023-13147-6","article-title":"The current state of liver transplantation for colorectal liver metastases in the United States: a call for standardized reporting","volume":"30","author":"Sasaki","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.21037\/hbsn.2020.03.10","article-title":"The potential use of extended criteria donors and eligible recipients in liver transplantation for unresectable colorectal liver metastases in central Sweden","volume":"10","author":"Villard","year":"2021","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib70","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ajt.2023.09.001","article-title":"Living donor liver transplantation for colorectal cancer liver metastases: midterm outcomes at a single center in North America","volume":"24","author":"Kaltenmeier","year":"2024","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.117054_bib71","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.117054_bib72","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-009-0521-6","article-title":"Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center","volume":"16","author":"Carpizo","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.117054_bib73","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1245\/s10434-023-14840-2","article-title":"Metastatic colorectal cancer treated with combined liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): predictive factors for early recurrence","volume":"31","author":"Grange","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.117054_bib74","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bjs.10838","article-title":"Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases","volume":"105","author":"Margonis","year":"2018","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.117054_bib75","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","article-title":"Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system","volume":"189","author":"Iwatsuki","year":"1999","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.117054_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","article-title":"Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients","volume":"247","author":"Rees","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.117054_bib77","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1245\/s10434-023-13652-8","article-title":"Liver transplantation after hepatic artery infusion pump therapy: single-center experience and technical considerations","volume":"30","author":"Hill","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.117054_bib78","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1245\/s10434-023-13674-2","article-title":"Is hepatic artery infusion pump therapy a new bridging strategy to liver transplant for advanced liver malignancy?","volume":"30","author":"He","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026002394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026002394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:00:48Z","timestamp":1781208048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961026002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":78,"alternative-id":["S0002961026002394"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.117054","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary management of unresectable or borderline operable colorectal cancer liver metastases: a review and modern treatment algorithm","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.117054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117054"}}